Trends in Botulinum Toxin Use among Patients with Multiple Sclerosis: A Population-Based Study

Trends in Botulinum Toxin Use among Patients with Multiple Sclerosis: A Population-Based Study

There are limited real-world data on the use of botulinum toxin type A (BoNT-A) in patients with multiple sclerosis (MS). Accordingly, this nationwide, population-based, retrospective cohort study aimed to describe BoNT-A treatment trends in patients with MS between 2014 and 2020 in France. This stu...

Full description

Bibliographic Details
Main Authors: Djamel Bensmail, Pierre Karam, Anne Forestier, Jean-Yves Loze, Jonathan Lévy
Format: Article
Language:English
Published: MDPI AG 2023-04-01
Series:Toxins
Subjects:
botulinum toxin
France
multiple sclerosis
spasticity
neurogenic detrusor overactivity
Online Access:https://www.mdpi.com/2072-6651/15/4/280

Internet

https://www.mdpi.com/2072-6651/15/4/280

Similar Items